Report cover image

E-prescribing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Publisher Fortune Business Insights Pvt. Ltd.
Published Jan 01, 2025
Length 140 Pages
SKU # FOB19847096

Description

Growth Factors of E-prescribing Market

The global e-prescribing market has experienced significant growth in recent years, with its size valued at USD 863.6 million in 2018 and projected treach USD 8,633.7 million by 2032, exhibiting a Compound Annual Growth Rate (CAGR) of 17.5% during the forecast period.

Understanding E-Prescribing

Electronic prescribing, or e-prescribing, is a technological framework that allows medical practitioners telectronically generate and transmit prescriptions tpharmacies. This system enhances patient safety and healthcare quality by checking for drug interactions and reducing medication errors. It alsoffers a more convenient and cost-effective alternative ttraditional prescription methods.

Market Trends and Drivers

A significant trend propelling the e-prescribing market is the integration of e-prescribing software with Electronic Health Record (EHR) systems. Integrated EHRs provide comprehensive features such as laboratory results, clinical notes, and decision support tools that standalone systems may lack. This integration improves the availability of patient medication histories and pharmacy benefits information, thereby reducing prescription errors and enhancing patient care. Government initiatives promoting the adoption of integrated EHRs further bolster this trend.

The growing adoption of integrated EHR solutions is a primary driver of market growth. These solutions simplify prescription processes and offer better access tmedical histories compared tstandalone systems. Government efforts treduce administrative burdens on healthcare providers by implementing integrated e-prescribing EHR solutions contribute significantly tthis growth. For example, the introduction of the Cures Act on December 13, 2016, aims tenhance medical product development and foster innovations in medical technology.

Another critical driver is the increasing focus on eliminating adverse drug events (ADEs) and medical errors. Prescription faults account for over 70% of medication errors reported in general practice settings and hospitals. ADEs are among the leading causes of death in the U.S., with studies indicating that over 90,000 deaths occur annually due tmedical errors. E-prescribing systems allow healthcare providers taccess patient medical histories and medication information, thereby reducing medical errors and enhancing patient safety.

Market Segmentation

The e-prescribing market is segmented based on delivery mode, prescription type, and end-user.
  • Delivery Mode: The market is divided intweb-based and on-premise systems. Web-based e-prescribing systems are projected tregister a lucrative CAGR during the forecast period. These systems dnot require complex installations or extensive IT support, making them cost-effective and convenient. The increasing adoption of integrated EHR solutions alspropels the growth of web-based systems.
  • Prescription Type: The market is categorized intcontrolled substances and non-controlled substances. Electronic prescribing of controlled substances, such as opioids, ensures proper use and minimizes the risk of drug abuse. The non-controlled substances segment is expected twitness stable growth due tthe increasing adoption of e-prescription technology in managing drug usage and the rising prevalence of chronic disorders.
  • End User: End-users include hospitals, physician's offices, and pharmacies. Hospitals are projected thold the maximum market share due tthe increasing adoption of e-prescription integrated EHR solutions in hospital settings. Physician's offices are alsadopting these solutions tenhance patient care and streamline prescription processes.
Regional Insights

North America held the largest e-prescribing market share, with a revenue of USD 399.61 million in 2018. This dominance is attributed ta flexible regulatory environment and increased funding from both private and public organizations. The region's well-established healthcare infrastructure and high adoption rate of advanced technologies contribute tmarket growth.

Challenges and Restraints

Despite the benefits, certain factors may limit the adoption of e-prescribing solutions. The high cost associated with the implementation and maintenance of integrated e-prescribing solutions is a significant barrier, especially in developing economies. Additionally, the lack of healthcare IT support in various developing countries restricts market growth.

Future Outlook

The e-prescribing market is poised for substantial growth, driven by technological advancements, government initiatives, and the increasing need treduce medical errors. The integration of e-prescribing systems with EHRs and the adoption of web-based solutions are expected tcontinue as dominant trends. Addressing challenges such as high implementation costs and lack of IT support in developing regions will be crucial for sustained growth.

In conclusion, the e-prescribing market is undergoing a transformative phase, with significant growth opportunities on the horizon. Stakeholders, including healthcare providers, technology developers, and policymakers, must collaborate tharness the full potential of e-prescribing systems, ultimately enhancing patient safety and healthcare efficiency.

ATTRIBUTE DETAILS

Study Period - 2015-2026

Base Year - 2018

Forecast Period - 2019-2026

Historical Period - 2015-2017

Unit - Value (USD million)

Segmentation By Delivery Mode
  • Web-based
  • On-premise
By Prescription Type
  • Controlled substance
  • Non controlled Substances
By End User
  • Physician’s Office
  • Hospitals
  • Pharmacies
By Geography
  • North America (the U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.

Table of Contents

140 Pages
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Recent Industry Developments Such as Mergers & Acquisitions
4.2. Regulatory Scenario for Key Countries
4.3. Technological Advancements Pertaining to E-prescribing Solutions
4.4. Data on EHR Adoption for Key Countries
4.5. Key Industry Trends
4.6. New Product Launch
5. Global E- prescribing Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Delivery Mode
5.2.1. Web-based
5.2.2. On-premise
5.3. Market Analysis, Insights and Forecast – By Prescription Type
5.3.1. Controlled substance
5.3.2. Non Controlled substance
5.4. Market Analysis, Insights and Forecast – By End User
5.4.1. Physician’s Office
5.4.2. Hospitals
5.4.3. Pharmacies
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America E- prescribing Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Delivery Mode
6.2.1. Web-based
6.2.2. On-premise
6.3. Market Analysis, Insights and Forecast – By Prescription Type
6.3.1. Controlled substance
6.3.2. Non Controlled substance
6.4. Market Analysis, Insights and Forecast – By End User
6.4.1. Physician’s Office
6.4.2. Hospitals
6.4.3. Pharmacies
6.5. Market Analysis, Insights and Forecast - By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe E- prescribing Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Delivery Mode
7.2.1. Web-based
7.2.2. On-premise
7.3. Market Analysis, Insights and Forecast – By Prescription Type
7.3.1. Controlled substance
7.3.2. Non Controlled substance
7.4. Market Analysis, Insights and Forecast – By End User
7.4.1. Physician’s Office
7.4.2. Hospitals
7.4.3. Pharmacies
7.5. Market Analysis, Insights and Forecast - By Country/Sub Region
7.5.1. U.K.
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Scandinavia
7.5.7. Rest of Europe
8. Asia Pacific E- prescribing Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast – By Delivery Mode
8.2.1. Web-based
8.2.2. On-premise
8.3. Market Analysis, Insights and Forecast – By Prescription Type
8.3.1. Controlled substance
8.3.2. Non Controlled substance
8.4. Market Analysis, Insights and Forecast – By End User
8.4.1. Physician’s Office
8.4.2. Hospitals
8.4.3. Pharmacies
8.5. Market Analysis, Insights and Forecast - By Country/Sub Region
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Southeast Asia
8.5.6. Rest of Asia Pacific
9. Latin America E- prescribing Market Analysis, Insights and Forecast, 2015-2026
9.1. Key Findings / Summary
9.2. Market Analysis, Insights and Forecast – By Delivery Mode
9.2.1. Web-based
9.2.2. On-premise
9.3. Market Analysis, Insights and Forecast – By Prescription Type
9.3.1. Controlled substance
9.3.2. Non Controlled substance
9.4. Market Analysis, Insights and Forecast – By End User
9.4.1. Physician’s Office
9.4.2. Hospitals
9.4.3. Pharmacies
9.5. Market Analysis, Insights and Forecast - By Country/Sub Region
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East & Africa E- prescribing Market Analysis, Insights and Forecast, 2015-2026
10.1. Key Findings / Summary
10.2. Market Analysis, Insights and Forecast – By Delivery Mode
10.2.1. Web-based
10.2.2. On-premise
10.3. Market Analysis, Insights and Forecast – By Prescription Type
10.3.1. Controlled substance
10.3.2. Non Controlled substance
10.4. Market Analysis, Insights and Forecast – By End User
10.4.1. Physician’s Office
10.4.2. Hospitals
10.4.3. Pharmacies
10.5. Market Analysis, Insights and Forecast - By Country/Sub Region
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2018)
11.3. Competition Dashboard
11.4. Comparative Analysis – Major Players
11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
11.5.1. Epic Systems Corporation
11.5.1.1. Overview,
11.5.1.2. Products & services,
11.5.1.3. SWOT analysis,
11.5.1.4. Recent developments,
11.5.1.5. strategies,
11.5.1.6. financials (based on availability)
11.5.2. Cerner Corporation
11.5.2.1. Overview,
11.5.2.2. Products & services,
11.5.2.3. SWOT analysis,
11.5.2.4. Recent developments,
11.5.2.5. strategies,
11.5.2.6. financials (based on availability)
11.5.3. Allscripts Healthcare, LLC
11.5.3.1. Overview,
11.5.3.2. Products & services,
11.5.3.3. SWOT analysis,
11.5.3.4. Recent developments,
11.5.3.5. strategies,
11.5.3.6. financials (based on availability)
11.5.4. Medical Information Technology, Inc. (MEDITECH)
11.5.4.1. Overview,
11.5.4.2. Products & services,
11.5.4.3. SWOT analysis,
11.5.4.4. Recent developments,
11.5.4.5. strategies,
11.5.4.6. financials (based on availability)
11.5.5. Athenahealth
11.5.5.1. Overview,
11.5.5.2. Products & services,
11.5.5.3. SWOT analysis,
11.5.5.4. Recent developments,
11.5.5.5. strategies,
11.5.5.6. financials (based on availability)
11.5.6. eClinicalWorks
11.5.6.1. Overview,
11.5.6.2. Products & services,
11.5.6.3. SWOT analysis,
11.5.6.4. Recent developments,
11.5.6.5. strategies,
11.5.6.6. financials (based on availability)
11.5.7. Surescripts
11.5.7.1. Overview,
11.5.7.2. Products & services,
11.5.7.3. SWOT analysis,
11.5.7.4. Recent developments,
11.5.7.5. strategies,
11.5.7.6. financials (based on availability)
11.5.8. Practice Fusion, Inc.
11.5.8.1. Overview,
11.5.8.2. Products & services,
11.5.8.3. SWOT analysis,
11.5.8.4. Recent developments,
11.5.8.5. strategies,
11.5.8.6. financials (based on availability)
11.5.9. NextGen Healthcare
11.5.9.1. Overview,
11.5.9.2. Products & services,
11.5.9.3. SWOT analysis,
11.5.9.4. Recent developments,
11.5.9.5. strategies,
11.5.9.6. financials (based on availability)
11.5.10. RelayHealth Corporation
11.5.10.1. Overview,
11.5.10.2. Products & services,
11.5.10.3. SWOT analysis,
11.5.10.4. Recent developments,
11.5.10.5. strategies,
11.5.10.6. financials (based on availability)
12. Strategic Recommendations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us